Big Pharma is scrambling to make a new drug to treat non-alcoholic fatty liver disease.

In the past, fatty liver disease was caused by alcohol and alcoholic hepatitis.  Of these 55 percent already had cirrhosis and alcoholic hepatitis. The financial pages recently included stories that Big Pharma looked at this new non-alcoholic fatty liver disease as a new opportunity to create new drugs to treat 30 million American adults including millions of children.  This new disease is caused by the new replacement for alcohol with sugar.